Optimal curtailed designs for single arm phase II clinical trials

From MaRDI portal

Publication:101301

Jump to:navigation, search

DOI10.48550/arXiv.1909.03017arXiv1909.03017MaRDI QIDQ101301

Martin Law, Michael J. Grayling, Adrian P. Mander

Publication date: 6 September 2019

Retrieved from "https://portal.mardi4nfdi.de/w/index.php?title=Publication:101301&oldid=33781882"